Hot Stocks: Brokerage view on Gland Pharma, Aditya Birla Fashion and PDS
The deal appears complementary to Gland in terms of EU market access, branded pharma customer base and some technologies, the brokerage said. “We see the scope of meaningful value unlocking, subject to synergy execution,” said the note.
